Recordati announces offer document filed with CONSOB
The document details the terms of the voluntary tender offer for all ordinary shares of the company.
See the latest news and media coverage for Recordati. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global pharmaceutical company
recordati.comLast updated
In short: Recordati faced a major delisting bid from a CVC and GBL consortium while delivering strong 2025 results and entering a key Moderna partnership.
The document details the terms of the voluntary tender offer for all ordinary shares of the company.
CVC Capital Partners IX Aggregator and Groupe Bruxelles Lambert, through Black Mountain S.à r.l., are the offerors. The offer is for all outstanding shares.
EBITDA grew 5.0% and adjusted net income rose 7.2%.
It showcases highlights on disease care advancement, leadership messages, financial results, culture, and commitments to patients and responsible growth.
Detailed price information for Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) from The Globe and Mail including charting and trades.
Moderna to receive up to $160 million in upfront and near-term development and regulatory milestones, in addition to commercial and sales milestones and tiered royalties...
The mega-operation of 10.7 billion euros with which Respighi BidCo S.p.A. aims for total control of Recordati, marking the act...
Recordati could soon leave Piazza Affari. The Italian pharmaceutical group has received an offer from CVC Capital Partners and Groupe Bruxelles Lambert for the...
Track Recordati and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Recordati and other trending companies.